(Q35942094)

11 August 2017

1 reference

title

Behavioural pharmacology of 5-HT3 receptor ligands (English)

1 reference

11 August 2017

1 reference

J. M. Barnes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553101

8 October 2022

N. M. Barnes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553101

8 October 2022

S. J. Cooper

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553101

8 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1553101

8 October 2022

publication date

1 January 1992

1 reference

Neuroscience & Biobehavioral Reviews

11 August 2017

published in

1 reference

11 August 2017

volume

16

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

107-113

1 reference

Differential effect of typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medical prefrontal cortical cells: a microiontophoretic study

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

[3H]zacopride: ligand for the identification of 5-HT3 recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Withdrawal syndrome following subchronic treatment with anxiolytic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Activation of a 5-HT3 receptor releases dopamine from rat striatal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Laterality of dopamine function and neuroleptic action in the amygdala in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The 5-HT4 receptor: naughty, but nice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Agonist-induced phosphoinositide hydrolysis in choroid plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Zacopride: anxiolytic profile in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: Drug interaction at presynaptic receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Actions of buspirone in a putative model of anxiety in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Exploration of mice in a black and white test box: validation as a model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Serotoninergic modulation of the dopamine response from the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The psychopharmacology of 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The effect of ondansetron on cognitive performance in the marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effects of 8-OH-DPAT, buspirone and ICS 205-930 on feeding in a novel environment: comparisons with chlordiazepoxide and FG 7142.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

1 reference

7 January 2021

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Centrally active 5-HT receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Drug reinforcement studied by the use of place conditioning in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Electrophysiology of 5-HT3 receptors in neuronal cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Acute non-opioid analgesia in defeated male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Zacopride, a potent 5-HT3 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

3HQuaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Ondansetron in treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980057-0

7 January 2021

10.1016/S0149-7634(05)80057-0

Identifiers

DOI

1 reference

11 August 2017

1 reference